Jazz Pharmaceuticals plc Files 2024 10-K
Ticker: JAZZ · Form: 10-K · Filed: Feb 26, 2025 · CIK: 1232524
| Field | Detail |
|---|---|
| Company | Jazz Pharmaceuticals PLC (JAZZ) |
| Form Type | 10-K |
| Filed Date | Feb 26, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, pharmaceuticals, financials
TL;DR
Jazz Pharma dropped its 2024 10-K. Full financials and biz details out now.
AI Summary
Jazz Pharmaceuticals plc filed its 2024 10-K on February 26, 2025, reporting on its fiscal year ending December 31, 2024. The company, incorporated in L2 and headquartered in Dublin, operates in the pharmaceutical preparations sector. Key financial details and business operations for the fiscal year are outlined in this comprehensive filing.
Why It Matters
This filing provides investors and analysts with a detailed overview of Jazz Pharmaceuticals' financial performance, strategic initiatives, and risk factors for the 2024 fiscal year, crucial for understanding the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Jazz Pharmaceuticals faces inherent risks related to drug development, regulatory approvals, market competition, and patent expirations.
Key Numbers
- 2024 — Fiscal Year (The period covered by the 10-K filing.)
- 1231 — Fiscal Year End (Indicates the end date of the reporting period.)
- 001-33500 — SEC File Number (Unique identifier for the company's SEC filings.)
Key Players & Entities
- Jazz Pharmaceuticals plc (company) — Filer of the 10-K
- 20241231 (date) — Fiscal year end
- 20250226 (date) — Filing date
- Dublin (location) — Company headquarters
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What were Jazz Pharmaceuticals' total revenues for the fiscal year ended December 31, 2024?
The provided text does not contain specific revenue figures for the fiscal year ended December 31, 2024.
What is the company's primary business segment as indicated by its SIC code?
The company's SIC code is 2834, which corresponds to Pharmaceutical Preparations.
When was this 10-K filing submitted to the SEC?
This 10-K filing was submitted to the SEC on February 26, 2025.
Where is Jazz Pharmaceuticals plc headquartered?
Jazz Pharmaceuticals plc is headquartered in Dublin.
What is the SEC Accession Number for this filing?
The SEC Accession Number for this filing is 0001232524-25-000011.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 26, 2025 regarding Jazz Pharmaceuticals plc (JAZZ).